James R. Empfield

Companies

• Xenon PharmaceuticalsSVP, Drug Discovery Feb 9, 2016 to Mar 12, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• XPXenon Pharmaceuticals XENE10,000 shares²$347.8K at $34.78Aug 12, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 12, 2022Sold 21,875 shares at $38.68 of Xenon Pharmaceuticals²
• Aug 12, 2022Sold 35,868 shares at $38.08 of Xenon Pharmaceuticals²
• Aug 12, 2022Shares withheld for tax 7,257 shares at $38.02 of Xenon Pharmaceuticals²
• Aug 12, 2022Exercised options 45,000 shares at $4.75 of Xenon Pharmaceuticals²
• Aug 12, 2022Exercised options 20,000 shares at $3.10 of Xenon Pharmaceuticals²
• Mar 7, 2022Sold 31,048 shares at $30.54 of Xenon Pharmaceuticals³
• Mar 7, 2022Sold 1,805 shares at $30.62 of Xenon Pharmaceuticals³
• Mar 7, 2022Shares withheld for tax 8,952 shares at $30.23 of Xenon Pharmaceuticals³
• Mar 7, 2022Exercised options 40,000 shares at $6.76 of Xenon Pharmaceuticals³
• Mar 7, 2022Shares withheld for tax 695 shares at $30.23 of Xenon Pharmaceuticals³
• Mar 7, 2022Exercised options 2,500 shares at $8.40 of Xenon Pharmaceuticals³
• Mar 4, 2022Sold 18,315 shares at $30.79 of Xenon Pharmaceuticals³
• Mar 4, 2022Shares withheld for tax 6,685 shares at $31.42 of Xenon Pharmaceuticals³
• Mar 4, 2022Exercised options 25,000 shares at $8.40 of Xenon Pharmaceuticals³